Alzheimer's related Press Releases
New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth
New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimer's Disease Market Sales of Acetylcholinesterase Inhibitors,... Read more...
Twin study: Diabetes significantly increases risk for Alzheimer's disease and other dementia
Twin study: Diabetes significantly increases risk for Alzheimer's disease and other dementia Getting diabetes before 65 more than doubles risk for Alzheimer's disease Diabetics have a significantly
... Read more...Antipsychotic drugs double risk of death among Alzheimer's patients
Antipsychotic drugs double risk of death among Alzheimer's patients New research into the effects of antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication
... Read more...GlaxoSmithKline, AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimera's disease candidate vaccine
GlaxoSmithKline and AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimera's disease candidate vaccines GlaxoSmithKline Biologicals S.A. (GSK) and AFFiRiS GmbH announced
... Read more...AstraZeneca PLC (AZN) and Targacept, Inc. (TRGT) Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Diseas
AstraZeneca PLC (AZN) and Targacept, Inc. (TRGT) Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease AstraZeneca and Targacept, Inc. today announced that results from... Read more...
PRESS RELEASE: Biogen Idec and Neurimmune Announce $380M Alliance to Develop Treatments for Alzheimer's Diseases
Biogen Idec and Neurimmune Announce $380M Alliance to Develop Treatments for Alzheimer's Diseases Cambridge, MA and Zürich, Switzerland, November 20, 2007 – Biogen Idec and Neurimmune... Read more...
PRESS RELEASE: Children With Alzheimer's Disease Risk Gene Show Reduced Cognitive Function
Children With Alzheimer's Disease Risk Gene Show Reduced Cognitive Function Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive... Read more...
PRESS RELEASE: An Alzheimer’s Vaccine?
Oklahoma City, Nov. 12, 2007 – Could a new vaccine be the key to stopping Alzheimer’s disease? A new research study from the Oklahoma Medical Research Foundation shows that immunization could... Read more...
PRESS RELEASE: Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease
Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease MONTVALE, N.J., Nov. 2 -- Memory Pharmaceuticals Corp. today announced positive top-line data from the... Read more...
PRESS RELEASE: UCLA scientists pinpoint a possible physical origin of Alzheimer's disease
UCLA scientists pinpoint a possible physical origin of Alzheimer's disease Discovery suggests new ways to treat disorder's cause, not just symptoms FINDINGS: For some time, scientists have blamed... Read more...
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges




